ES2127937T3 - Procedimiento para la preparacion de derivados de indolizina. - Google Patents

Procedimiento para la preparacion de derivados de indolizina.

Info

Publication number
ES2127937T3
ES2127937T3 ES94925630T ES94925630T ES2127937T3 ES 2127937 T3 ES2127937 T3 ES 2127937T3 ES 94925630 T ES94925630 T ES 94925630T ES 94925630 T ES94925630 T ES 94925630T ES 2127937 T3 ES2127937 T3 ES 2127937T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
pct
indolizine derivatives
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925630T
Other languages
English (en)
Inventor
Satoshi Okada
Kozo Sawada
Akio Kuroda
Shinya Watanabe
Hirokazu Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2127937T3 publication Critical patent/ES2127937T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN NUEVO PROCEDIMENTO PARA PREPARAR UN COMPUESTO DE FORMULA (I).
ES94925630T 1993-09-10 1994-09-06 Procedimiento para la preparacion de derivados de indolizina. Expired - Lifetime ES2127937T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318790A GB9318790D0 (en) 1993-09-10 1993-09-10 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
ES2127937T3 true ES2127937T3 (es) 1999-05-01

Family

ID=10741816

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925630T Expired - Lifetime ES2127937T3 (es) 1993-09-10 1994-09-06 Procedimiento para la preparacion de derivados de indolizina.

Country Status (12)

Country Link
US (1) US5780633A (es)
EP (1) EP0717742B1 (es)
JP (1) JP3160909B2 (es)
KR (1) KR100339068B1 (es)
CN (1) CN1043992C (es)
AT (1) ATE173259T1 (es)
CA (1) CA2171308A1 (es)
DE (1) DE69414586T2 (es)
ES (1) ES2127937T3 (es)
GB (1) GB9318790D0 (es)
HU (1) HU216156B (es)
WO (1) WO1995007279A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
CN101094852A (zh) 2004-11-01 2007-12-26 惠氏公司 作为cns活性剂的取代的吲嗪以及衍生物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334716A (en) * 1991-06-17 1994-08-02 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic derivatives

Also Published As

Publication number Publication date
CN1043992C (zh) 1999-07-07
ATE173259T1 (de) 1998-11-15
JPH09502200A (ja) 1997-03-04
GB9318790D0 (en) 1993-10-27
HU9600606D0 (en) 1996-05-28
CA2171308A1 (en) 1995-03-16
KR100339068B1 (ko) 2002-11-23
HU216156B (hu) 1999-04-28
EP0717742B1 (en) 1998-11-11
US5780633A (en) 1998-07-14
DE69414586D1 (de) 1998-12-17
WO1995007279A3 (en) 1995-04-27
EP0717742A1 (en) 1996-06-26
DE69414586T2 (de) 1999-04-29
HUT74290A (en) 1996-11-28
KR960704889A (ko) 1996-10-09
WO1995007279A2 (en) 1995-03-16
JP3160909B2 (ja) 2001-04-25
CN1130907A (zh) 1996-09-11

Similar Documents

Publication Publication Date Title
FI960399A0 (fi) Perhydroisoindolijohdannaisia P-aineen antagonisteina
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
TW263499B (es)
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
ATE259815T1 (de) Neue antagonistische verbindungen
IL127598A0 (en) A process for preparing iso-taxol analogs
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
BR9507381A (pt) Composto uso de um composto processo para o tratamento de um manifero composição famacèutica e processo para a preparação de compostos
ES2127937T3 (es) Procedimiento para la preparacion de derivados de indolizina.
BR9400016A (pt) Processo para preparação de compostos, e compostos
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
TW261605B (es)
AU7467694A (en) Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
ES2147601T3 (es) Procedimiento para la preparacion de 3-amino-2-cloro-4-alquil-piridinas o 3-amino-2-cloro-4-cicloalquil-piridinas.
SE9401596D0 (sv) New compounds
ES2172699T3 (es) Procedimiento para la preparacion de prostaglandina e1.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717742

Country of ref document: ES